PNC Financial Services Group Inc. Sells 5,347 Shares of Aflac Incorporated (NYSE:AFL)

PNC Financial Services Group Inc. trimmed its position in Aflac Incorporated (NYSE:AFL - Free Report) by 2.2% during the first quarter, according to its most recent 13F filing with the SEC. The fund owned 236,206 shares of the financial services provider's stock after selling 5,347 shares during the period. PNC Financial Services Group Inc.'s holdings in Aflac were worth $26,264,000 as of its most recent filing with the SEC.

A number of other hedge funds have also recently bought and sold shares of AFL. GAMMA Investing LLC boosted its stake in Aflac by 12,313.9% in the first quarter. GAMMA Investing LLC now owns 1,504,067 shares of the financial services provider's stock valued at $167,237,000 after acquiring an additional 1,491,951 shares during the last quarter. Northern Trust Corp boosted its stake in Aflac by 22.9% in the fourth quarter. Northern Trust Corp now owns 7,296,014 shares of the financial services provider's stock valued at $754,700,000 after acquiring an additional 1,357,753 shares during the last quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC boosted its stake in Aflac by 11.9% in the fourth quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC now owns 5,250,905 shares of the financial services provider's stock valued at $543,154,000 after acquiring an additional 556,394 shares during the last quarter. Universal Beteiligungs und Servicegesellschaft mbH bought a new position in Aflac in the fourth quarter valued at approximately $48,081,000. Finally, Mercer Global Advisors Inc. ADV bought a new position in Aflac in the fourth quarter valued at approximately $42,409,000. 67.44% of the stock is currently owned by institutional investors.

Analyst Upgrades and Downgrades

A number of equities analysts have issued reports on the stock. Raymond James Financial reduced their price objective on shares of Aflac from $115.00 to $110.00 and set an "outperform" rating on the stock in a research note on Thursday, May 29th. Wall Street Zen cut shares of Aflac from a "hold" rating to a "sell" rating in a research note on Monday, May 5th. Wells Fargo & Company lifted their price target on shares of Aflac from $103.00 to $105.00 and gave the stock an "equal weight" rating in a research report on Thursday, July 10th. Morgan Stanley lifted their price target on shares of Aflac from $100.00 to $105.00 and gave the stock an "equal weight" rating in a research report on Monday, May 19th. Finally, Barclays set a $98.00 price target on shares of Aflac and gave the stock an "underweight" rating in a research report on Monday, July 7th. Three investment analysts have rated the stock with a sell rating, eight have given a hold rating and three have assigned a buy rating to the company's stock. According to MarketBeat, Aflac has a consensus rating of "Hold" and a consensus target price of $108.15.

Aflac Stock Up 0.5%

Shares of AFL stock opened at $98.60 on Tuesday. The company has a current ratio of 0.09, a quick ratio of 0.09 and a debt-to-equity ratio of 0.29. Aflac Incorporated has a 1 year low of $95.97 and a 1 year high of $115.50. The firm's fifty day moving average price is $102.50 and its two-hundred day moving average price is $105.00. The firm has a market capitalization of $53.31 billion, a P/E ratio of 15.41, a PEG ratio of 3.03 and a beta of 0.83.

Insider Buying and Selling at Aflac

In other news, Director Masatoshi Koide sold 37,000 shares of the business's stock in a transaction dated Tuesday, May 20th. The shares were sold at an average price of $105.59, for a total transaction of $3,906,830.00. Following the transaction, the director directly owned 70,992 shares in the company, valued at $7,496,045.28. The trade was a 34.26% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. Also, Director Arthur Reginald Collins sold 2,750 shares of the business's stock in a transaction dated Thursday, May 15th. The stock was sold at an average price of $105.70, for a total transaction of $290,675.00. Following the transaction, the director owned 6,728 shares in the company, valued at $711,149.60. This represents a 29.01% decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last three months, insiders have sold 40,750 shares of company stock worth $4,304,295. Insiders own 0.80% of the company's stock.

Aflac Profile

Aflac Incorporated, through its subsidiaries, provides supplemental health and life insurance products. The company operates through Aflac Japan and Aflac U.S. segments. The Aflac Japan segment offers cancer, medical, nursing care, work leave, GIFT, and whole and term life insurance products, as well as WAYS and child endowment plans under saving type insurance products in Japan.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.